Mef2d-rearranged Acute Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-24
Clinical Trial Update: BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients [Phase 2]
A Phase 2 clinical trial update notes BEBT-908 plus chemotherapy for CR MRD-positive MEF2D-rearranged and pre-B acute lymphoblastic leukemia…